Antonios Isaac's most recent trade in Mangoceuticals Inc was a trade of 60,000 Common Stock done . Disclosure was reported to the exchange on April 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Mangoceuticals Inc | Antonios Isaac | Director, President | 10 Apr 2025 | 60,000 | 60,000 | - | 0 | Common Stock | ||
Live Ventures Inc | Antonios Isaac | Director | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 30 Jun 2023 | 9,904 | 30,000 (1%) | 0% | 25.8 | 256,018 | Common Stock |
Live Ventures Inc | Antonios Isaac | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.18 per share. | 13 Jun 2023 | 25,000 | 55,000 (3%) | 1% | 15.2 | 379,500 | Common Stock |
Live Ventures Inc | Antonios Isaac | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 25,000 | 0 | - | - | Common Stock Option | |
Live Ventures Inc | Antonios Isaac | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.14 per share. | 13 Jun 2023 | 15,096 | 39,904 (2%) | 0% | 25.1 | 379,513 | Common Stock |
ALT5 Sigma Corp. | Antonios Isaac | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 125,787 | 217,787 (11%) | 6% | 0 | Common Stock | |
Live Ventures Inc | Antonios Isaac | Director, Fin. Plan/Strategist/Economist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 25,000 | 25,000 | - | - | Stock Option | |
Live Ventures Inc | Antonios Isaac | Director, Fin. Plan/Strategist/Economist | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Jan 2021 | 25,000 | 25,000 | - | - | Stock Option |